# Study of Enfuvirtide in HIV-Positive Subjects

> **NCT00086710** · PHASE1 · COMPLETED · sponsor: **Trimeris** · enrollment: 26 (—)

## Conditions studied

- HIV Infections
- AIDS

## Interventions

- **DRUG:** Fuzeon

## Key facts

- **NCT ID:** NCT00086710
- **Lead sponsor:** Trimeris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 26 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086710, "Study of Enfuvirtide in HIV-Positive Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00086710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*